ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Sunshine Biopharma’s Canadian subsidiary, Nora Pharma launches biosimilar drug, Niopeg: Fort Lauderdale, Florida Friday, July 4, 2025, 14:00 Hrs [IST] Sunshine Biopharma Inc., a ...

Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage ...